Alibaba, Airbnb Lead Friday's Market Cap Stock Movers
Friday's market has seen significant movements in a range of stocks, with some experiencing sharp increases while others face ...
Recursion Pharmaceuticals Needs A Clinical Breakthrough To Pique Interest
Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...
Unusually active option classes on open February 14th
Recursion Pharmaceuticals (RXRX), Crispr Therapeutics (CRSP), iShares MSCI India (INDA), Faraday Future Intelligent Electric (FFIE), Bilibili (BILI), Procter & Gamble (PG), UP Fintech Holding Ltd ...
Hosted on MSN20h
Biotechs on the Brink: 2 Stocks With Huge Potential
Investors know the biotech industry is a waiting game—smaller companies in this space often work to secure the funding to ...
Nvidia Dumps SoundHound, Trims Arm Stake, Buys These 2 Stocks
Nvidia disclosed in a regulatory filing Friday that it sold off three tech stocks and added stakes in two others. Nvidia ...
Recursion Pharmaceuticals (RXRX) Laps the Stock Market: Here's Why
In the most recent trading session, Recursion Pharmaceuticals (RXRX) closed at $8.50, indicating a +1.92% shift from the previous trading day.
Recursion: CDK7 Inhibitor Differentiation Is Initially Paying Off
Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.
Recursion Pharmaceuticals (RXRX) Stock Jumps 8.9%: Will It Continue to Soar?
Recursion Pharmaceuticals (RXRX) was a big mover last session on higher-than-average trading volume. The latest trend in ...
Recursion Pharmaceuticals’ (RXRX) AI Approach to Drug Discovery Shows Progress
Recursion Pharmaceuticals (RXRX) is a clinical-stage biotechnology company utilizing artificial intelligence to expedite drug ...